This 2006 narrative review by Coleman synthesizes clinical data on the presentation, natural history, and prognostic factors of metastatic bone disease across cancer types. It asks: which patients are at highest risk for skeletal complications, and what clinical and biochemical features predict that risk? The review draws on large datasets including the zoledronic acid phase 3 program (~3,000 patients) to define actionable thresholds.
When a patient with known malignancy presents with back pain that is worse at night and relieved by lying still, think metastatic cord compression — not degenerative disease. Get MRI urgently: ambulatory status at the time you start treatment is the single most important predictor of outcome, and the window to preserve function is narrow.
For any lytic long-bone lesion, calculate a Mirels score before the patient leaves the clinic. Score greater than 7 means call orthopedic oncology that day. Score 10 or above means prophylactic fixation is indicated. A completed pathologic fracture dramatically worsens quality of life and converts an elective case into an emergent one.
Use urinary NTX to risk-stratify patients with bone metastases: levels above 100 nmol/mmol creatinine signal high near-term risk for SREs and death across all tumor types, regardless of whether bisphosphonates are on board.
When counseling patients and families, primary tumor type is your first prognostic anchor: breast or prostate bone-only disease buys years, while lung cancer with bone metastases is measured in months. This distinction drives the intensity of surgical intervention you are willing to offer.
This 2006 narrative review by Coleman synthesizes clinical data on the presentation, natural history, and prognostic factors of metastatic bone disease across cancer types. It asks: which patients are at highest risk for skeletal complications, and what clinical and biochemical features predict that risk? The review draws on large datasets including the zoledronic acid phase 3 program (~3,000 patients) to define actionable thresholds.
When a patient with known malignancy presents with back pain that is worse at night and relieved by lying still, think metastatic cord compression — not degenerative disease. Get MRI urgently: ambulatory status at the time you start treatment is the single most important predictor of outcome, and the window to preserve function is narrow.
For any lytic long-bone lesion, calculate a Mirels score before the patient leaves the clinic. Score greater than 7 means call orthopedic oncology that day. Score 10 or above means prophylactic fixation is indicated. A completed pathologic fracture dramatically worsens quality of life and converts an elective case into an emergent one.
Use urinary NTX to risk-stratify patients with bone metastases: levels above 100 nmol/mmol creatinine signal high near-term risk for SREs and death across all tumor types, regardless of whether bisphosphonates are on board.
When counseling patients and families, primary tumor type is your first prognostic anchor: breast or prostate bone-only disease buys years, while lung cancer with bone metastases is measured in months. This distinction drives the intensity of surgical intervention you are willing to offer.